Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] - N0000191546

Pharmacologic Class Information

Pharmacologic Code N0000191546
Pharmacologic Name Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Pharmacologic Uses
  • hyperpolarization-activated cyclic nucleotide-gated channel blocker
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists

The following table contains 3 products whose active ingredient are classified under the same pharmacologic class Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
55513-800Corlanor Non-Proprietary Name: IvabradineTablet, Film CoatedOralAmgen IncACTIVE
55513-810Corlanor Non-Proprietary Name: IvabradineTablet, Film CoatedOralAmgen IncACTIVE
55513-813Corlanor Non-Proprietary Name: IvabradineSolutionOralAmgen IncACTIVE